Kinnate Biopharma Inc. (24) | Human Resources (15)

Browse by Subcategory

Bonus & Incentive Agreements (3 contracts)
Change of Control Agreements (5)
Compensation Agreements (2)
Employment Agreements (5)

Recent Contracts

Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 15, 2023)
Employment Letter between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
Change in Control and Severance Agreement between the Company and Neha Krishnamohan (Filed With SEC on June 7, 2021)
2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 30, 2020)
Outside Director Compensation Policy (Filed With SEC on November 30, 2020)
2018 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 13, 2020)
Employment Letter between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
Employment Letter between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
Employment Letter between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
Employment Letter between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)
Executive Incentive Compensation Plan (Filed With SEC on November 13, 2020)
Change in Control and Severance Agreement between the Registrant and Nima Farzan (Filed With SEC on November 13, 2020)
Change in Control and Severance Agreement between the Registrant and Mark Meltz (Filed With SEC on November 13, 2020)
Change in Control and Severance Agreement between the Registrant and Eric Murphy, Ph.D (Filed With SEC on November 13, 2020)
Change in Control and Severance Agreement between the Registrant and Richard Williams, MBBS, Ph.D (Filed With SEC on November 13, 2020)